Study to Evaluate the Safety, Tolerability, and Efficacy of BGE-175 in Hospitalized Adults With Coronavirus Disease 2019 (COVID-19) That Are Not in Respiratory Failure

PHASE2TerminatedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

April 20, 2022

Study Completion Date

May 19, 2022

Conditions
Covid19
Interventions
DRUG

BGE-175

Drug

OTHER

Placebo

Placebo

Trial Locations (26)

20904

Jadestone Clinical Research, LLC, Silver Spring

21201

University of Maryland Medical System, Baltimore

32209

University of Florida - Health, Jacksonville, Jacksonville

40503

Baptist Health, Lexington, Lexington

80631

North Colorado Medical Center, Greeley

85202

Banner Health, Mesa

90806

Long Beach Medical Center, Long Beach

91911

Velocity Clinical Research, Chula Vista, Chula Vista

92123

Sharp Memorial Hospital, San Diego

92868

UCI Center for Clinical Research, Orange

06904

Stamford Hospital, Stamford

C1426ABP

Clinica Privada Independencia, Ciudad Autonoma de Buenos Aires

C1039AAO

Sanatorio De La Trinidad Mitre, Buenos Aires

C1430EGF

Clinica Adventista Belgrano (CAB), Buenos Aires

29043-260

Hospital Universitário Cassiano Antônio de Moraes, Vitória

30180-080

Hospital Felicio Rocho (HFR), Belo Horizonte

96835-090

Centro de Pesquisa Hospital Ana Nery Santa Cruz do Sul, Santa Cruz do Sul

90160-093

Hospital Ernesto Dornelles, Porto Alegre

89801-355

Clínica Supera Oncologia, Chapecó

14784-400

Unidade de Pesquisa Clinica da Fundação Pio XII - Hospital de Amor de Barretos, Barretos

18618-687

Hospital das Clínicas da Faculdade de Medicina de Botucatu UNESP (HC-FMB/UNESP), Botucatu

13060-904

Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP) - Centro de Pesquisa São Lucas, Campinas

15090-000

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São José do Rio Preto

02432

Conjunto Hospitalar de Mandaqui, São Paulo

18040-425

Clinica de Alergia Martti Antila, Sorocaba

21040-360

Instituto Nacional de Infectologia Evandro Chagas / Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BioAge Labs, Inc.

INDUSTRY